An innovative pipeline enables rapid functional validation of novel causative genes in cholestatic liver diseases
Monday, May 1, 2023
9:15 AM – 9:30 AM ET
Location: Convention Center: 208 AB
Publication Number: 3075.6
Chunyue Yin, Cincinnati Children's Hospital, Cincinnati, OH, United States; Hannah M. Nartker, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Richard J. Thompson, King's College London, London, England, United Kingdom; Laura Bull, University of California, San Francisco, School of Medicine, San Francisco, CA, United States
Presenting Author(s)
Chunyue Yin, PhD (she/her/hers)
Associate Professor Cincinnati Children's Hospital Cincinnati, Ohio, United States
Disclosure(s):
Chunyue Yin, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Hannah M. Nartker, Bachelor's in Biochemistry: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Richard J. Thompson, MD PhD: Albireo Pharma (Ongoing) (Products/Services: Consultant); Generation Bio (Ongoing) (Products/Services: Advisory Committee, Consultant, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Mirum Pharma (Ongoing) (Products/Services: Consultant); Rectify Pharma (Ongoing) (Products/Services: Consultant, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Laura Bull, Ph.D.: Guidepoint Global (Terminated, June 23, 2021) (Products/Services: Consultant)
